Wendell David Associates Inc. held its position in Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent filing with the SEC. The firm owned 2,000 shares of the company’s stock at the end of the second quarter. Wendell David Associates Inc.’s holdings in Aetna were worth $304,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of AET. FTB Advisors Inc. boosted its position in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new position in Aetna during the first quarter valued at $133,000. Liberty Capital Management Inc. boosted its position in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares in the last quarter. Horan Capital Management acquired a new position in Aetna during the first quarter valued at $157,000. Finally, Guardian Life Insurance Co. of America boosted its position in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. Hedge funds and other institutional investors own 91.79% of the company’s stock.

Shares of Aetna Inc. (AET) traded up 0.75% during trading on Wednesday, reaching $154.46. The company had a trading volume of 331,261 shares. The stock’s 50-day moving average price is $151.11 and its 200-day moving average price is $135.17. The company has a market capitalization of $51.23 billion, a PE ratio of 47.11 and a beta of 0.54. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $155.93.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, May 2nd. The company reported $2.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.35. Aetna had a return on equity of 17.75% and a net margin of 1.84%. The company had revenue of $15.17 billion for the quarter, compared to analysts’ expectations of $15.39 billion. During the same period in the previous year, the firm posted $2.30 EPS. Aetna’s revenue was down 3.4% compared to the same quarter last year. On average, equities analysts expect that Aetna Inc. will post $8.99 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Thursday, July 13th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.30%. The ex-dividend date is Tuesday, July 11th. Aetna’s dividend payout ratio is currently 62.31%.

TRADEMARK VIOLATION WARNING: “Aetna Inc. (NYSE:AET) Position Maintained by Wendell David Associates Inc.” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/aetna-inc-nyseaet-position-maintained-by-wendell-david-associates-inc/1452493.html.

AET has been the subject of several recent analyst reports. Stifel Nicolaus restated a “buy” rating and issued a $150.00 price target (up previously from $130.00) on shares of Aetna in a research note on Wednesday, May 3rd. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $143.00 price objective for the company in a research report on Tuesday, April 4th. Royal Bank Of Canada reiterated a “buy” rating and set a $145.00 price objective on shares of Aetna in a research report on Monday, April 24th. Cantor Fitzgerald reiterated a “buy” rating and set a $150.00 price objective on shares of Aetna in a research report on Friday, May 12th. Finally, Cleveland Research upgraded Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Seven investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Aetna presently has a consensus rating of “Buy” and an average price target of $152.84.

In other news, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares in the company, valued at approximately $92,905,631.52. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,008,606.49. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.